Nationwide Blood Pressure Drug Recall As FDA Issues Fatal Warning
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Medscape4y
Intravitreal Injections and Endophthalmitis
The rapid growth in IVT injections has resulted from the introduction of novel drug therapies. In 2004, only 2 agents were specifically approved by the United States Food and Drug Administration ...